Combination with bispecific T-cell engagers amplifies T-cell recruitment and cytotoxic activity against tumor cells -- Düsseldorf, Germany, ...
Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into ...
New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050’s ...
Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...
A new study led by Swansea University has revealed a new way to potentially treat certain autoimmune diseases by targeting a ...
Bacteria use multiple defense mechanisms to survive in the host body. Shigella bacteria that cause colitis disable multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback